U.S. vaccine makers' pre-market share prices decline; Moderna down 3.4%, Novavax down 1.4%. FDA memo cites link between child deaths and COVID-19 vaccines.

lunes, 1 de diciembre de 2025, 5:56 am ET1 min de lectura
MRNA--
NVAX--
NVMI--
OVID--

U.S. vaccine makers' pre-market share prices decline; Moderna down 3.4%, Novavax down 1.4%. FDA memo cites link between child deaths and COVID-19 vaccines.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios